The Trump Administration and semaglutides
Semaglutides are turning out to be transformative for obesity in the way that statins have been transformative for hypercholesterolemia and anti-hypertensives have been transformative for high blood pressure: they’re not only highly effective but have minimal side effects. From a public health standpoint, there’s every reason to allow Medicare and Medicaid coverage for semaglutides. But […]
